Macey

Macey Levan

JD, PhD
Job Title: Associate Professor of Surgery and Population Health at NYU Grossman School of Medicine, Director, Center for Surgical and Transplant Applied Research Qualitative Core
Organization: NYU Langone Health

Dr. Macey Levan (Henderson) is an internationally recognized scientist and leader advancing organ donation and transplantation through research, policy, and patient-centered design, shaping complex public health systems and translating science into practice.

Dr. Levan is Associate Professor of Surgery and Population Health at NYU Grossman School of Medicine and Director of Policy & External Affairs for the NYU Langone Transplant Institute. She co-founded and now directs the Center for Surgical and Transplant Applied Research (CSTAR) Qualitative Core in the Department of Surgery.

Under her leadership, CSTAR has helped elevate NYU Surgery’s NIH funding ranking to #7 in just four years. She currently serves as PI on two NIH R01 awards and has authored more than 150 peer-reviewed publications across medicine, public health, ethics, and policy including in top medical journals like JAMA.

Previously at Johns Hopkins, Dr. Levan played a central role in growing the transplant research enterprise to over $100 million in NIH funding, helping to build one of the most influential transplant research programs in the world.

At the federal level, she served as an elected Director—and later Vice President of Patient & Donor Affairs—for the U.S. Organ Procurement and Transplantation Network under the U.S. Department of Health and Human Services. In that role, she helped guide national governance reform, modernization efforts, and policies affecting thousands of patients annually, championing transparency, accountability, and patient-centered design within one of healthcare’s most complex infrastructures.

Her work spans federal agencies, academic medical centers, professional societies, philanthropic partners, and international collaborators, preparing health systems for emerging innovations including advanced surgical technologies, xenotransplantation, and bioengineered organs.

Beyond research and policy, Dr. Levan views storytelling as essential to public trust. She leads global media and engagement strategy for an international scientific journal, produces podcast programming for a worldwide audience, and develops projects across television and digital media.

She serves on the Board of Directors of the Children’s Organ Transplant Association and mentors emerging clinicians and scientists nationwide.

At the center of her leadership is a simple conviction: science must advance with integrity, courage, and humanity—and always in service of patients and families.

Professional Information

Patient Groups: Adult
Areas of Practice: In-patient, Living Donation, Outreach, Post-transplant, Pre-Transplant, Procurement
Organs of Expertise: Kidney, Vascularized Composite Allograft (VCA)
Connections to the Cause: Living Donor, Other

Testimonial: Participating in the Alliance Innovation Leadership Council has given me more insight and ability to learn from, and collaborate with OPO professionals. As a transplant center person that is not a clinician, the opportunity for diverse perspectives on the procurement side is helpful. Not only does it improve my ability to ask and answer important questions, but provides me the ability to give back with my skills and talents in research, education, and program development.

Alliance Presentations

CovidVaccinations 408140131

COVID Vaccines & Transplantation: Where Are We Now?

Wednesday, November 30, 2022, at 2:00pm

Following the COVID-19 outbreak, all US citizens were encouraged to maximize protection efforts by getting all recommended vaccine doses and boosters, but there was concern about how the vaccine would affect the immunocompromised. For example, are there any special considerations for transplant recipients? During this webinar, we will welcome experts from Johns Hopkins and NYU Langone who will discuss the varying practices across the country and review what the outcome data shows thus far. Additionally, our panelists will discuss the impact of the new variants of COVID-19 on vaccine recommendations and monoclonal antibody associated immunoprotection.

Lifelong Networks

Our partners are the heart and soul of our organization. For more than 15 years, they have played a vital role providing quality education and programs to advance a shared mission.

X
Need help? Start here.